BioAge Labs, Inc. (BIOA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$9.59+0.95%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · BIOA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenues | 10.4 | 9.0 | — | — | — |
| Operating Expenses & Income | |||||
| R&D Expenses | 87.8 | 74.0 | 59.0 | 33.9 | — |
| Operating Income | (106.3) | (92.8) | (78.2) | (48.4) | — |
| Earnings from Continuing Operations | |||||
| Interest Expense | — | 0.7 | 2.4 | — | — |
| Other Non-Operating Income / Expenses | 11.8 | 12.2 | 7.1 | (15.5) | — |
| EBT, Incl. Unusual Items | — | (80.6) | (71.1) | (63.9) | — |
| Income Tax Expense | — | — | — | 0.0 | — |
| Net Income | |||||
| Net Income | (94.5) | (80.6) | (71.1) | (63.9) | — |
| Per Share | |||||
| Basic EPS | (2.11) | (2.24) | (6.63) | (38.17) | — |
| Diluted EPS | (2.11) | (2.24) | (6.63) | (38.17) | — |
| Revenue per Share | 0.23 | — | — | — | — |
| Basic Weighted Avg Shares | 44.8 | 35.9 | 10.7 | 1.7 | — |
| Diluted Weighted Avg Shares | 44.8 | 35.9 | 10.7 | 1.7 | — |
| Supplemental | |||||
| EBIT | (106.3) | (92.8) | (78.2) | (48.4) | — |
| Effective Tax Rate | — | — | — | 0.0% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.